29 minutes ago
Data from a study deploying mobile health units across Detroit, Michigan, found CKD stage ≥3 rates double the national average and increased rates in at-risk subgroups.
11 hours ago
Blauvelt discusses studies revealing that disease severity, injection frequency, pain, and geography all shape treatment preferences.
13 hours ago
Armstrong highlights several major takeaways from her portion of the AAD 2026 session titled 'IL-23 Innovation: New Data Addressing Plaque Psoriasis.'
14 hours ago
This episode explores the launch and accessibility of FDA-approved oral GLP-1 orforglipron, including availability through Amazon Pharmacy's same-day delivery service.
15 hours ago
Patel provides an inside perspective on one of the most diagnostically challenging cardiovascular conditions.